PART 3AUTHORISATION FOR CLINICAL TRIALS AND ETHICS COMMITTEE OPINION
Clinical trials conducted in F1countries other than the United Kingdom21
1
If the licensing authority receives a valid request for authorisation relating to a clinical trial which is or is to be conducted in F2another country as well as the United Kingdom, the licensing authority may, if they think fit, require the production by the sponsor of any one or more of the following—
a
an undertaking, given by the sponsor, to permit their premises in that country to be inspected by or on behalf of the licensing authority for the purpose of establishing whether the conditions and principles of good clinical practice are satisfied or adhered to in relation to that trial; or
b
an undertaking, given by the owner or occupier of any premises in that country at which the clinical trial is or is to be conducted, to permit those premises to be inspected by or on behalf of the licensing authority for the purpose of establishing whether the conditions and principles of good clinical practice are satisfied or adhered to in relation to that trial.
2
If a sponsor fails to produce an undertaking required by the licensing authority in accordance with paragraph (1), that failure constitutes a ground for not accepting the request for authorisation, for the purposes of regulations 18 to 20.